print small large

This application is a service of the Singapore Government.

Health Sciences Authority

Chinese Proprietary Medicines


Having recognised the role of traditional Chinese medicine in the local context, HSA has taken steps to regulate products and practices in this area. HSA's Chinese Proprietary Medicines (CPM) Unit was set up in 1996 to administer regulatory control on CPM, with the following aims:

  • To ensure that CPM sold in Singapore are safe and of good quality;
  • To ensure that CPM are labelled appropriately; and
  • To facilitate prompt withdrawal of CPM from the market when necessary.


  • 在新加坡上市的中成药的安全和品质
  • 中成药的标签符合要求
  • 在必要时可迅速地将药品从市场上回收。

For more information on what is considered as a CPM and the regulatory controls in Singapore, please refer to this page.